Clearside Biomedical, Inc. (CLSDQ) vs Trevena, Inc. (TRVN)
Clearside Biomedical, Inc. and Trevena, Inc. are both Biotechnology companies. Clearside Biomedical, Inc. is the larger, with a market value of $2.2M against $1.8M — 1.2× the size. Clearside Biomedical, Inc. grew revenue faster over the last twelve months: −56.8% against −83.0%. Clearside Biomedical, Inc. has the higher net margin (−780.9% vs −6,233.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Clearside Biomedical, Inc. leads on 10 and Trevena, Inc. on 6.
Valuation
Profitability
| Metric | CLSDQ | TRVN | Biotechnology median |
|---|---|---|---|
| Gross margin | 92.55% | (190.29%) | 65.16% |
| Operating margin | (689.76%) | (5,879.85%) | 0.00% |
| Net margin | (780.93%) | (6,233.70%) | 0.00% |
| Free cash flow margin | (653.23%) | (4,961.72%) | 0.00% |
| Return on equity | 58.59% | 344.49% | (57.72%) |
| Return on assets | (127.43%) | (105.83%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack